{"DataElement":{"publicId":"3778593","version":"1","preferredName":"Disease Status Leukemia Chemosensitivity Type","preferredDefinition":"the status of a disease._Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better._Something distinguishable as an identifiable class based on common qualities._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","longName":"2177998v1.0:3778591v1.0","context":"OHSU Knight","contextVersion":"1","DataElementConcept":{"publicId":"2177998","version":"1","preferredName":"Disease Status","preferredDefinition":"the status of a disease.","longName":"DZ_STAT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177151","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A disease is any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. (from Wikipedia)","longName":"Disease","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A50-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Updated to add EVS concept preferred name. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2181646","version":"1","preferredName":"Status","preferredDefinition":"a condition or state at a particular time.","longName":"Status","context":"CIP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C0449438","definition":"A condition or state at a particular time.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4A6A07C-55DD-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-08","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB8BD084-7217-0DB5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-07","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-11-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3778591","version":"1","preferredName":"Leukemia Chemosensitivity Type","preferredDefinition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better._Something distinguishable as an identifiable class based on common qualities._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","longName":"LEUK_CHEM_SENS_TYP","context":"OHSU Knight","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Refractory within 6 months","valueDescription":"Refractory within 6 months","ValueMeaning":{"publicId":"3778592","version":"1","preferredName":"Refractory within 6 months","longName":"3778592","preferredDefinition":"Resistant to treatment or cure within the previous 6 months.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED4C78D-78F7-AD52-E040-BB89AD4360A2","latestVersionIndicator":"Yes","beginDate":"2013-06-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED4C78D-7910-AD52-E040-BB89AD4360A2","beginDate":"2013-06-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"},{"value":"Refractory","valueDescription":"Refractory","ValueMeaning":{"publicId":"2566882","version":"1","preferredName":"Refractory","longName":"2566882","preferredDefinition":"Not responding to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Refractory","conceptCode":"C38014","definition":"Not responding to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D24F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-22","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-22","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED4C78D-7925-AD52-E040-BB89AD4360A2","beginDate":"2013-06-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"},{"value":"Resistant","valueDescription":"Resistance","ValueMeaning":{"publicId":"2674643","version":"1","preferredName":"Resistance","longName":"2674643","preferredDefinition":"Failure of a cancer to shrink after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resistance","conceptCode":"C19391","definition":"Failure of a cancer to shrink after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"384C7304-8808-48E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED4C78D-7930-AD52-E040-BB89AD4360A2","beginDate":"2007-09-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"},{"value":"Sensitive","valueDescription":"Sensitivity","ValueMeaning":{"publicId":"2676533","version":"1","preferredName":"Sensitivity","longName":"2676533","preferredDefinition":"A measure of the minimum change in an input signal that an instrument can detect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sensitivity","conceptCode":"C68816","definition":"A measure of the minimum change in an input signal that an instrument can detect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395037C6-23FC-52BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED4C78D-793B-AD52-E040-BB89AD4360A2","beginDate":"2006-06-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED4C78D-7946-AD52-E040-BB89AD4360A2","beginDate":"2007-09-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"},{"value":"Untreated","valueDescription":"Without Therapeutic Procedure","ValueMeaning":{"publicId":"2676532","version":"1","preferredName":"Without Therapeutic Procedure","longName":"2676532","preferredDefinition":"Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395037C6-23C9-52BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED4C78D-7951-AD52-E040-BB89AD4360A2","beginDate":"2007-09-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"},{"value":"Relapse","valueDescription":"Relapse","ValueMeaning":{"publicId":"2857244","version":"1","preferredName":"Relapse","longName":"2857244","preferredDefinition":"The return of signs and symptoms of cancer after a period of improvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relapse","conceptCode":"C18265","definition":"The return of signs and symptoms of cancer after a period of improvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66219F23-0990-8382-E040-BB89AD432D5C","latestVersionIndicator":"Yes","beginDate":"2009-03-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-03-27","modifiedBy":"KUMMEROA","dateModified":"2023-11-17","changeDescription":null,"administrativeNotes":"2023.3.9 Added Alt VM per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED597C1-1CE7-1A08-E040-BB89AD437B32","beginDate":"2013-06-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"ONEDATA","dateModified":"2013-06-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2724589","version":"1","preferredName":"Chemosensitivity Type","preferredDefinition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.:Type; a subdivision of a particular kind of thing.","longName":"C71488:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemosensitivity","conceptCode":"C71488","definition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4455D875-2DF8-060D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-01-22","modifiedBy":"ONEDATA","dateModified":"2008-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED4C78D-78E3-AD52-E040-BB89AD4360A2","latestVersionIndicator":"Yes","beginDate":"2013-06-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"SOKKERL","dateModified":"2017-12-28","changeDescription":"OHSU 7195 ghd 06.10.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"DS_STAT_LEUK_CHEMOSEN_TYPE","type":"Context Short Name","context":"OHSU Knight"},{"name":"2177998v1.0:3778591v1.0","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Disease status","type":"Preferred Question Text","description":"Disease status","url":null,"context":"OHSU Knight"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED4C78D-795C-AD52-E040-BB89AD4360A2","latestVersionIndicator":"Yes","beginDate":"2013-06-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-10","modifiedBy":"FORMBUILDER","dateModified":"2015-09-14","changeDescription":"OHSU 7195 ghd 06.10.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}